Leap Therapeutics Inc (NASDAQ: LPTX) is -87.31% lower on its value in year-to-date trading and has touched a low of $0.39 and a high of $4.79 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The LPTX stock was last observed hovering at around $0.45 in the last trading session, with the day’s loss setting it -0.09%.
Currently trading at $0.36, the stock is -12.25% and -53.69% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 4.47 million and changing -19.56% at the moment leaves the stock -83.44% off its SMA200. LPTX registered -84.80% loss for a year compared to 6-month loss of -85.92%. The firm has a 50-day simple moving average (SMA 50) of $0.78782 and a 200-day simple moving average (SMA200) of $2.203215.
The stock witnessed a -24.03% gain in the last 1 month and extending the period to 3 months gives it a -87.38%, and is -11.05% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 18.86% over the week and 9.89% over the month.
Leap Therapeutics Inc (LPTX) has around 52 employees, a market worth around $13.98M and $0.00M in sales. Distance from 52-week low is -5.98% and -92.38% from its 52-week high. The company has generated returns on investments over the last 12 months (-192.75%).
The EPS is expected to grow by 43.65% this year
67.0 institutions hold shares in Leap Therapeutics Inc (LPTX), with institutional investors hold 54.14% of the company’s shares. The shares outstanding are 38.33M, and float is at 28.57M with Short Float at 5.38%. Institutions hold 52.30% of the Float.